NCT04115566招募中不适用
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- Primary Objective
研究概览
简要总结
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 10 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female ≥ 10 years of age
- •Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
- •Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
排除标准
- •1. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.
结局指标
主要结局
Primary Objective
时间窗: 2019-2035
The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.
次要结局
- Secondary Objective(2019-2035)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Hidradenitis SuppurativaNCT03248531UCB Biopharma SRL90
进行中（未招募）
3 期
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaHidradenitis SuppurativaNCT06468228AbbVie1,400
进行中（未招募）
2 期
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyHidradenitis SuppurativaNCT05139602AbbVie210
招募中
不适用
Clinical and Biological Characteristics of Hidradenitis SuppurativaHidradenitis SuppurativaNCT03967600University of California, San Francisco1,000
终止
不适用
Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis SuppurativaHidradenitis SuppurativaNCT05830149Henry Ford Health System1